Search Within

Adam Boruchov

Formats
  1. Meeting Abstract (9)
  2. Journal Article (5)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (12)
  2. Department of Medicine (12)
  3. Hematologic Malignancies, Division of (12)
  4. Bone Marrow Transplant (11)
  5. Adult Leukemia (7)
  6. Myeloma (4)

More Groups

People
  1. James Young (9)
  2. Raymond Comenzo (9)
  3. Stephen Nimer (7)
  4. Martin Fleisher (6)
  5. Ping Zhou (6)
  6. Adam Olshen (5)

More People

Years
  1. 2010 (1)
  2. 2008 (5)
  3. 2007 (4)
  4. 2006 (2)
  5. 2005 (1)
  6. 2004 (1)

More Years

Publications
  1. Blood (8)
  2. Journal of Clinical Oncology (2)
  3. Amyloid (1)
  4. Bone Marrow Transplantation (1)
  5. Haematologica (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. American Society of Clinical Oncology (2)
  3. American Society for Clinical Investigation (1)
  4. CRC Press/Taylor & Francis Group (1)
  5. Ferrata Storti Foundation (1)
  6. Nature Publishing Group (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia
    Journal Article

    Kantarjian, H.; Fenaux, P.; Sekeres, M. A.; Becker, P. S.; Boruchov, A.; Bowen, D.; Hellstrom-Lindberg, E.; Larson, R. A.; Lyons, R. M.; Muus, P.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The inhibitory Fcy-receptor IIB (CD32B) is highly expressed on clonal plasma cells from patients with systemic light-chain (AL) amyloidosis and provides a target for monoclonal antibody therapy
    Book Section

    Zhou, P.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Fleisher, M.; Young, J.; Boruchov, A.; Comenzo, R. L.
    In Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. (Eds.) XIth International Symposium on Amyloidosis (2008)

    Fulltext@MSK | Save
  • CD32B expression reflects phenotypic and functional heterogeneity in multiple myeloma (MM)
    Meeting Abstract

    Zhou, P.; Boruchov, A. M.; Hoffman, J. E.; Mo, Q. X.; Olshen, A.; Glasner, E.; Bonvini, E.; Koenig, S.; Drieghe, E.; Fleisher, M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy
    Journal Article

    Zhou, P.; Comenzo, R. L.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Maslak, P. G.; Fleisher, M.; Hoffman, J.; Jhanwar, S.; Young, J. W.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease
    Journal Article

    Hassoun, H.; Flombaum, C.; D'Agati, V. D.; Rafferty, B. T.; Cohen, A.; Klimek, V. M.; Boruchov, A.; Kewalramani, T.; Reich, L.; Nimer, S. D.; more...
    Bone Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Evaluating safety and efficacy of AMG 531 for the treatment of thrombocytopenic patients with myelodysplastic syndrome (MDS): Preliminary results of a phase 1/2 study
    Meeting Abstract

    Kantarjian, H. M.; Giles, F. J.; Fenaux, P.; Becker, P. S.; Boruchov, A. M.; Bowen, D. T.; HellstroĢˆm-Lindberg, E.; Larson, R. A.; Lyons, R. M.; Muus, P.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • CD32B in multiple myeloma and systemic AL-amyloidosis
    Meeting Abstract

    Boruchov, A. M.; Zhou, P.; Olshen, A.; Rankin, C.; Bonvini, E.; Koenig, S.; Fleisher, M.; McKenzie, S.; Maslak, P.; Jhanwar, S.; more...
    Haematologica (2007)

    Fulltext@MSK | Save
  • Phase 1/2 study of AMG 531 in thrombocytopenic patients (pts) with low-risk Myelodysplastic syndrome (MDS): Update including extended treatment
    Meeting Abstract

    Kantarjian, H.; Fenaux, P.; Sekeres, M. A.; Becker, P.; Boruchov, A.; Bowen, D.; Larson, R.; Lyons, R.; Muus, P.; Shammo, J.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • High dose chemotherapy and autologous stem cell transplantation with melphalan in patients with monoclonal immunoglobulin deposition disease associated with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Rafferty, B. T.; Flombaum, C.; D'Agati, V. D.; Klimek, V. M.; Cohen, A.; Boruchov, A.; Kewalramani, T.; Reich, L.; Landau, H.; more...
    Blood (2007)

    Fulltext@MSK | Save